Bioforce Nanosciences Holdings annual operating margin
2017
2018
2019
Bioforce Nanosciences Holdings Operating Margin Growth & History (BFNH)
Bioforce Nanosciences Holdings's operating margin was −261.82% for fiscal 2019.
View full Bioforce Nanosciences Holdings company overviewBioforce Nanosciences Holdings annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2019 | 2019-12-31 | −261.82% | +147.38 pp |
| 2018 | 2018-12-31 | −409.20% | +285.49 pp |
| 2017 | 2017-12-31 | −694.69% | — |
Bioforce Nanosciences Holdings quarterly operating margin
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q4.19
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2019 | 2019-12-31 | −2,017,000.00% | — |
| Q3 2019 | 2019-09-30 | −106.24% | +14.28 pp |
| Q2 2019 | 2019-06-30 | −120.46% | +423.37 pp |
| Q1 2019 | 2019-03-31 | −219.69% | — |
| Q3 2018 | 2018-09-30 | −120.52% | — |
| Q2 2018 | 2018-06-30 | −543.84% | — |
Bioforce Nanosciences Holdings operating margin trends
Between the periods ended 2017-12-31 and 2019-12-31, Bioforce Nanosciences Holdings's operating margin increased from −694.69% to −261.82%, a change of +432.87 percentage points. The latest reported quarter, Q4 2019, shows −2,017,000.00%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioforce Nanosciences Holdings source filings ↗